BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 25591557)

  • 1. Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance.
    Lin L; Du T; Huang J; Huang LL; Yang DZ
    Chin Med J (Engl); 2015 Jan; 128(2):169-74. PubMed ID: 25591557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNAs expression profiling of rat ovaries displaying PCOS with insulin resistance.
    Zhang C; Yu C; Lin Z; Pan H; Li K; Ma H
    Arch Gynecol Obstet; 2020 Nov; 302(5):1205-1213. PubMed ID: 32757043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of microRNAs and genes associated with hyperandrogenism in the follicular fluid of women with polycystic ovary syndrome.
    Xue Y; Lv J; Xu P; Gu L; Cao J; Xu L; Xue K; Li Q
    J Cell Biochem; 2018 May; 119(5):3913-3921. PubMed ID: 29193229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of microRNA profile in human cumulus granulosa cells: Identification of microRNAs that regulate Notch signaling and are associated with PCOS.
    Xu B; Zhang YW; Tong XH; Liu YS
    Mol Cell Endocrinol; 2015 Mar; 404():26-36. PubMed ID: 25622783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of serum microRNAs profile of PCOS and identification of novel non-invasive biomarkers.
    Long W; Zhao C; Ji C; Ding H; Cui Y; Guo X; Shen R; Liu J
    Cell Physiol Biochem; 2014; 33(5):1304-15. PubMed ID: 24802714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes.
    Sørensen AE; Wissing ML; Englund AL; Dalgaard LT
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1579-89. PubMed ID: 26771704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
    Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
    Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles for long non-coding RNAs in ovarian granulosa cells from women with PCOS with or without hyperandrogenism.
    Jin L; Yang Q; Zhou C; Liu L; Wang H; Hou M; Wu Y; Shi F; Sheng J; Huang H
    Reprod Biomed Online; 2018 Nov; 37(5):613-623. PubMed ID: 30224242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Expression of microRNAs in the Ovaries from Letrozole-Induced Rat Model of Polycystic Ovary Syndrome.
    Li D; Li C; Xu Y; Xu D; Li H; Gao L; Chen S; Fu L; Xu X; Liu Y; Zhang X; Zhang J; Ming H; Zheng L
    DNA Cell Biol; 2016 Apr; 35(4):177-83. PubMed ID: 26745201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome.
    Jiang L; Huang J; Chen Y; Yang Y; Li R; Li Y; Chen X; Yang D
    Endocrine; 2016 Jul; 53(1):280-90. PubMed ID: 26860517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of miRNAs in the uterus from a letrozole-induced rat PCOS model.
    Li C; Chen L; Zhao Y; Chen S; Fu L; Jiang Y; Gao S; Liu Z; Wang F; Zhu X; Rao J; Zhang J; Zhou X
    Gene; 2017 Jan; 598():20-26. PubMed ID: 27777110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of MiRNA in polycystic ovary syndrome (PCOS).
    Chen B; Xu P; Wang J; Zhang C
    Gene; 2019 Jul; 706():91-96. PubMed ID: 31054362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of microRNA in the Pathogenesis of Polycystic Ovary Syndrome.
    Chen Z; Ou H; Wu H; Wu P; Mo Z
    DNA Cell Biol; 2019 Aug; 38(8):754-762. PubMed ID: 31305133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome.
    Mukherjee S; Shaikh N; Khavale S; Shinde G; Meherji P; Shah N; Maitra A
    Eur J Endocrinol; 2009 May; 160(5):855-62. PubMed ID: 19211708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-483-5p and miR-486-5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome.
    Shi L; Liu S; Zhao W; Shi J
    Reprod Biomed Online; 2015 Oct; 31(4):565-72. PubMed ID: 26283014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs in patients with polycystic ovary syndrome.
    Ding CF; Chen WQ; Zhu YT; Bo YL; Hu HM; Zheng RH
    Hum Fertil (Camb); 2015 Mar; 18(1):22-9. PubMed ID: 25268995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of microRNAs that Regulate the MAPK Pathway in Human Cumulus Cells from PCOS Women with Insulin Resistance.
    Hu MH; Zheng SX; Yin H; Zhu XY; Lu FT; Tong XH; Liu YS; Zhang YW; Xu B
    Reprod Sci; 2020 Mar; 27(3):833-844. PubMed ID: 32046427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome.
    Koika V; Georgopoulos NA; Piouka A; Roupas ND; Karela A; Armeni AK; Katsantoni E; Panidis D
    Eur J Endocrinol; 2012 Apr; 166(4):695-702. PubMed ID: 22223701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.